Overview
Cerebrolysin is a unique, porcine-derived proteolytic peptide mixture consisting of low-molecular-weight amino acids and essential neurotrophic factors. Unlike many synthetic peptides used for general biohacking, this compound is primarily utilized in clinical settings to address severe neurological trauma and chronic cognitive decline. It serves as a potent intervention for individuals recovering from strokes, traumatic brain injuries (TBI), and advanced neurodegenerative disorders, where it works to preserve and repair neuronal architecture.
The peptide functions by creating a supportive environment for brain cells, promoting synaptic plasticity and improving glucose transport via GLUT-1 upregulation. Because it contains naturally occurring fragments like nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), it offers a multi-modal approach to brain health. While widely used internationally for conditions such as vascular dementia and Parkinson's disease, it remains a specialized tool for intensive neurological support and recovery.
Mechanism of action
This porcine-derived neuropeptide blend reduces neuroinflammation by inhibiting microglial activity and interleukin-1β release, while simultaneously lowering amyloid-beta levels and mimicking the effects of natural neurotrophic factors like BDNF and NGF.
Reported benefits
- ▸Enhances recovery and motor function following ischemic or hemorrhagic strokes.
- ▸Slows the progression of neurodegenerative conditions like Alzheimer’s and Parkinson’s.
- ▸Provides neuroprotective effects to shield brain tissue from inflammatory damage.
- ▸Supports cognitive clarity, memory retention, and focus in aging adults.
- ▸May improve peripheral nerve health by supporting axonal myelination.
Reported side effects
- ·Dizziness
- ·Headache
- ·Sweating
- ·Injection site irritation
- ·Agitation or insomnia (rare)
Often stacked with
P-21Standard stroke rehabilitation protocols